I know this can to zero, it could move up to $15 too!
The shorties are the biggest morons here, only time will tell.
At these prices if they did not cove means they are willing to take a huge risk. Always the saying "For a long the loss is what he paid and for a short all hell broke loose it could be 20/25 too per share"
Not the same story at all with $15 per share. No reason whatsoever for any sane company to buyout Affymax. I can believe, however, that a sane company may pay something for the chance, although as Affymax itself described it as "highly unlikely", that Omontys may be reintroduced into the commercial market, but that such a payment would be as a result of an asset sale, probably through Chapter 11 reorganization, where the Affymax shareholders would not benefit.